OMRON Launches Blood Pressure Monitor Production at First India Factory

OMRON Healthcare Co., Ltd., a global leader in clinically proven medical devices for home health monitoring, has commenced full-scale blood pressure monitor production at its first factory in India, located near Chennai, Tamil Nadu. Operated by OMRON HEALTHCARE MANUFACTURING INDIA Pvt. Ltd., the approximately 24,000-square-meter facility at ORIGINS by Mahindra houses five production lines manufacturing blood pressure monitors for the Indian market. The factory produces the HEM-7090, HEM-7181, and HEM-7183T series, leveraging production technologies and quality-control expertise from OMRON's Matsusaka factory in Japan and its Vietnam facility to meet the same standards of measurement accuracy and quality as its international devices. These models range from straightforward devices for first-time users to high-end units featuring Trend Indicator and Bluetooth connectivity with the OMRON Connect app, all designed to meet the needs and price expectations of Indian consumers. The initiative supports the government's Make in India initiative through local component sourcing, workforce development, and employment creation.

This milestone comes as India faces substantial cardiovascular healthcare challenges, with approximately 300 million people estimated to be living with hypertension and cardiovascular diseases among the country's leading causes of death, according to the World Health Organization. As India's economy grows at approximately 7% annually, lifestyle changes are expected to further increase hypertension prevalence, yet fewer than 5% of households have a home blood pressure monitor in regular use. OMRON Healthcare has operated in India since 2010, raising awareness of hypertension and collaborating with healthcare professionals, including working with the Indian Society of Hypertension on the development of India's first home blood pressure monitoring guidelines. The company aims to increase the Chennai factory's production capacity tenfold by 2028 and introduce nebulizer production for respiratory conditions such as asthma. The announcement was disseminated via NEWMEDIAWIRE.

Ayumu Okada, President and CEO of OMRON Healthcare, said, "Under the OMRON Group's long-term vision, Shaping the Future 2030, we are working to address three key social challenges: achieving carbon neutrality, realizing a digital society, and extending healthy life expectancy. OMRON Healthcare's role is to contribute to the third of these, helping people monitor their health as a natural part of everyday life and access appropriate medical care when needed." He added that the commencement of full-scale production in Chennai is an important step toward ensuring a stable supply of medical-grade blood pressure monitors in India and supporting healthier lives across the country.